Hikma stock gains as oil prices and market tone shift

Published on 09/01/2026 at 20:55 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Hikma stock moves with a firmer market backdrop on September 1, 2026, while the latest visible quote points to GBX 1,616 and a market cap of GBX 342.14 billion.

Isometrisches 3D-Diagramm der pharmazeutischen Wertschöpfungskette mit Fabrik und Lager — Hikma Pharmaceuticals PLC GB00B128J450 illustriert isometrisches 3D-Diagramm der pharmazeutischen Wertschöpfungskette von Rohstoff bis Vertrieb, Illustration mit AI erstellt.

Hikma Pharmaceuticals PLC (GB00B128J450) stock traded at GBX 1,616.00 on September 1, 2026, with a day range of GBX 1,609.00 to GBX 1,631.00 and a market value of GBX 342.14 billion. The move came as broader markets were softer, and Reuters reported on September 1, 2026, that global risk sentiment remained under pressure from higher yields and oil prices.

Market level stays in view

For investors, the key point is the price band: the stock was quoted close to the top of its intraday range, which leaves the session structure more important than a single tick. Morningstar showed a previous close of GBX 1,568.00, so the visible quote stood GBX 48.00 above that level.

The stock is still anchored by a large valuation base, with market capitalization at GBX 342.14 billion on September 1, 2026. That makes the daily move a function of a heavy-cap stock rather than a small-cap headline swing.

What the latest figures show

On the operating side, the freshest visible company figures in the available material point to a very large revenue base and an earnings mix that remains central for valuation. The search set did not surface a current Hikma release, so the article stays with the dated market snapshot and the most recent broad market context instead of forcing a stale operating update into a same-day frame.

Reuters also reported that the S&P 500 fell 50.7 points, or 0.66 percent, at the open to 7,635.47 on September 1, 2026, which helps explain why defensive positioning mattered across the session. Hikma stock therefore reads less like a standalone rerating and more like part of a cautious market tape.

Go deeper

Hikma stock and the latest market snapshot

A compact view of the share price, market value, and the broader market tone that shaped trading on September 1, 2026.

Open Hikma coverage Investor Relations

Hikma and its medicines base

Hikma Pharmaceuticals PLC is best known for branded and injectable medicines, and that mix typically keeps revenue tied to hospital demand, product launches, and supply discipline. In a market session like September 1, 2026, that business profile matters because stable cash generation is often valued more than a sharp sentiment swing.

Share price and valuation

At GBX 1,616.00 as of September 1, 2026, Hikma stock traded with a visible spread inside the session, while the market cap of GBX 342.14 billion framed the size of the move. The previous close of GBX 1,568.00 shows the stock was up GBX 48.00 from the prior session, which is the most concrete comparison in the current snapshot.